Intellia Therapeutics (NTLA) Shareholder's Equity (2015 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shareholder's Equity (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 595,226.00
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 14.38 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 19.36 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 31.42 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 1.08 Bn
10 Intellia Therapeutics 1.63 Bn 1.63 Bn - 620.94 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 620.94 Mn
Dec 31, 2025 671.39 Mn
Sep 30, 2025 748.42 Mn
Jun 30, 2025 715.26 Mn
Mar 31, 2025 779.92 Mn
Dec 31, 2024 871.96 Mn
Sep 30, 2024 962.62 Mn
Jun 30, 2024 971.06 Mn
Mar 31, 2024 1.04 Bn
Dec 31, 2023 1.05 Bn
Sep 30, 2023 1.04 Bn
Jun 30, 2023 1.10 Bn
Mar 31, 2023 1.19 Bn
Dec 31, 2022 1.24 Bn
Sep 30, 2022 824.95 Mn
Jun 30, 2022 880.55 Mn
Mar 31, 2022 953.75 Mn
Dec 31, 2021 1.04 Bn
Sep 30, 2021 1.11 Bn
Jun 30, 2021 494.81 Mn
Mar 31, 2021 545.87 Mn
Dec 31, 2020 527.07 Mn
Sep 30, 2020 329.62 Mn
Jun 30, 2020 351.59 Mn
Mar 31, 2020 247.76 Mn
Dec 31, 2019 269.88 Mn
Sep 30, 2019 275.65 Mn
Jun 30, 2019 276.87 Mn
Mar 31, 2019 264.34 Mn
Dec 31, 2018 277.92 Mn
Sep 30, 2018 263.27 Mn
Jun 30, 2018 279.34 Mn
Mar 31, 2018 295.50 Mn
Dec 31, 2017 300.60 Mn
Sep 30, 2017 175.85 Mn
Jun 30, 2017 187.59 Mn
Mar 31, 2017 199.88 Mn
Dec 31, 2016 209.84 Mn
Sep 30, 2016 218.12 Mn
Jun 30, 2016 223.60 Mn
Mar 31, 2016 -27.14 Mn
Dec 31, 2015 -21.20 Mn